Home > Healthcare > Medical Devices > Diagnostic Devices > Immunohematology Market

Immunohematology Market Trends

  • Report ID: GMI1652
  • Published Date: Jul 2021
  • Report Format: PDF

Immunohematology Market Trends

Hematological disease is a disorder associated with the blood and blood forming organs. It includes sickle cell anemia, thalassemia, lymphoma, leukemia, hemophilia, among others. For instance, according to the World Health Organization, approximately 4,74,519 number of leukemia new cases reported in the year 2020 and more than 3,11,594 deaths occurred due to leukemia in 2020. The increasing prevalence of leukemia around the world is one of the prime factors fostering the industry growth. Additionally, activities such as healthcare infrastructure upgradation, favorable government initiatives as well as increasing R&D expenses in the diagnosis and treatment of various hematological disorders are expected to have an optimistic impact on the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size surpassed USD 2.4 billion in 2020 and will grow at a CAGR of 4% from 2021 to 2027.

Reagents recorded a revenue of over USD 1.5 billion in 2020 and will grow owing to their wide range of uses including the determination of group and Rh phenotype, analysis of the ABO system, and the identification of infrequent antibodies.

Polymerase chain reaction (PCR) registered a revenue of USD 857.9 million in 2020 and will depict appreciable growth driven by the increasing number of serological tests and the rising prevalence of hematological disorders.

The North America market will grow at a rate of 3.7% between 2021 and 2027 propelled by the high prevalence of leukemia in the region.

Immunohematology Market Scope

Buy Now


Premium Report Details

  • Base Year: 2020
  • Companies covered: 13
  • Tables & Figures: 194
  • Countries covered: 18
  • Pages: 150
 Download Free Sample